With tariffs driving up the cost of China-sourced APIs and packaging, American CDMOs with local supply chains are suddenly faster, higher quality, and even cheaper.

As tariffs rise and the government pushes for more domestic production, new opportunities for private equity investment are opening up in the U.S. CDMO market.

Mass General Brigham is working with K Health to provide AI pre-visits to patients who lack primary care. They should extend it to everyone.

Qualtrics’ acquisition of Press Ganey isn’t just another data or survey deal, it’s a pivotal moment for AI in healthcare.

The HealthBiz podcast has moved to CareTalk: Healthcare Unfiltered. Please follow us there:

• Spotify

• Apple

• All other audio players

• YouTube

• CareTalk website